Australia, Nov. 3 -- PROMEGA Corp., owns the trademark (2683810) for 'EMBERSCRIPT' till June 5, 2036.
Status: protected:
Registered/protected
Class: 1 [Enzymes for scientific and research purposes; reverse transcription enzymes for scientific and laboratory use; enzymes and enzyme preparations for use in reverse transcription, reverse transcription quantitative polymerase chain reaction (RT-qPCR), digital polymerase chain reaction (dPCR), nucleic acid amplification, nucleic acid analysis, and gene expression analysis.]
Type of Mark: Word
Date of Acceptance: Aug. 26
Registration Advertised: Nov. 2
For further details contact S.C. David W. Staple Casimir Jones.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2683810.
Disclaimer: Curated by HT Syndication.
